Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BridgeBio Pharma Inc (BBIO) vs Chewy Inc (CHWY) Price & Performance

BridgeBio Pharma IncTrade

Price performance (Past 24H)

Key statistics

BridgeBio Pharma Inc vs Chewy Inc — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B), while Chewy Inc trades at $22.57 (market cap $9.20B). The key difference: BridgeBio Pharma Inc is the larger of the two by market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, Chewy Inc nearer its low. Which is the better fit depends on your goals.

BBIOCHWY
Market Cap
$16.36B$9.20B
Sector
HealthConsumer Cyclical
52-Week High
$90.17$42.33
52-Week Low
$47.29$17.51
Enterprise Value
$18.14B$9.16B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About BridgeBio Pharma Inc

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.

Read more on BBIO

About Chewy Inc

Chewy is the largest e-commerce pet care retailer in the U.S., generating $8.9 billion in 2021 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a standalone company in 2019, after spending a couple of years developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods, like crates, leashes, and bowls.

Read more on CHWY